Hims and other telehealth companies make finasteride easy to get and don’t have to disclose side effects in ads.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

In recent years, telehealth companies like Hims and Keeps have revolutionized access to hair loss treatments by offering ...

Telehealth companies like Hims & Hers (HIMS) are aggressively marketing hair-loss medications to young men, with some patients saying they ...

Believe it or not, there's something worse than male pattern baldness. It's depression, plunging libido and shrinking genitals. Those are the symptoms doct ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

Hims & Hers Health (NYSE: HIMS) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...

Hims Topical Finasteride & Minoxidil Spray is ... this specific product isn’t FDA-approved. Thinning hair and hair loss can occur for a variety of reasons. Determining the underlying cause ...

With the FDA shutting down its key revenue stream, Hims faces a tough road ahead--can it justify its valuation?

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operation | Hims & Hers ...